PDCD1 and Hodgkins lymphoma: Notably, among HL patients receiving 10^7/kg CAR-T cells plus PD-1-blocking antibody, five out of six (83.3%) showed CR, while patients receiving 10^6/kg CAR-T cells (Cohort 1) did not achieve CR.